Rhode Island is still grappling with soaring numbers of drug overdose deaths, many of them involving the painkiller fentanyl. It's not clear the message about the dangers of fentanyl is reaching those at risk.
Rhode Island health officials have rolled out a new campaign against drug addiction. The campaign debuts as the state faces more grim statistics: 232 Rhode Islanders died from apparent accidental drug overdoses in 2014, the same number as in 2013.
You may see their faces on buses, or hear their voices in public service announcements. They’re people in recovery from addiction. They include Jonathan Goyer, a former addict turned recovery counselor. He said it will take more than advertising to fight drug addiction.
Woonsocket-based pharmacy giant CVS has signed a deal with drug maker Gilead to offer its hepatitis C drugs Sovaldi and Harvoni, exclusively, for treating hepatitis C.
The deal covers patients enrolled in drug benefit plans managed by CVS. And the news comes on the heels of AbbVie's announcement of a deal with CVS competitor Express Scripts, which will offer AbbVie's hepatitis C treatment, Viekira Pak, exclusively.
Second quarter financial results from the Woonsocket-based pharmacy chain CVS Caremark have beat analyst expectations. That’s due in part to new specialty pharmacy business and the opening of more in-store clinics.
More Rhode Island babies are being born dependent on the opioid drugs (including OxyContin and heroin) their pregnant mothers were taking. Many of these babies need hospital stays and powerful medication to help them through the painful withdrawal. Now, researchers at Women & Infants Hospital are trying to pin down what treatments work best, and what the long-term impacts are. Part one of our two-part series on newborns in withdrawal.